WallStreetZenWallStreetZen

NYSE: OGN
Organon & Co Stock

$29.76-0.65 (-2.14%)
Updated Feb 3, 2023
OGN Price
$29.76
Fair Value Price
N/A
Market Cap
$7.57B
52 Week Low
$22.88
52 Week High
$39.48
P/E
7.48x
P/B
-7.1x
P/S
0.95x
PEG
0.51x
Dividend Yield
2.82%
Revenue
$6.29B
Earnings
$1.01B
Gross Margin
63.5%
Operating Margin
23.09%
Profit Margin
16.1%
Debt to Equity
-10.79
Operating Cash Flow
$638M
Beta
0.67
Next Earnings
Feb 16, 2023
Ex-Dividend
N/A
Next Dividend
N/A

OGN Overview

Organon & Co. offers prescription drugs in the U.S. and internationally. Its Women's Health portfolio includes contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. Its Biosimilars portfolio consists immunology products (Brenzys, Renflexis, and Hadlima), as well as oncology products (Ontruzant and Aybintio). The company also offers cholesterol-modifying cardiovascular products (Zetia, Ezetrol, Vytorin, Inegy, Rosuzet, and Zocor). Organon & Co. was incorporated in 2020 and is headquartered in Jersey City, NJ.

Zen Score

Industry Average (43)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how OGN scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

OGN ($29.76) is trading below its intrinsic value of $46.11, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
OGN is good value based on its earnings relative to its share price (7.48x), compared to the US market average (15.09x)
P/E vs Market Valuation
OGN is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 35 more OGN due diligence checks available for Premium users.

Be the first to know about important OGN news, forecast changes, insider trades & much more!

OGN News

Valuation

OGN price to earnings (PE)

For valuing profitable companies with steady earnings
Company
7.48x
Industry
30.81x
Market
15.09x
OGN is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
OGN is good value based... subscribe to Premium to read more.
P/E vs Market Valuation

OGN price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
-7.1x
Industry
5.14x

OGN price to earnings growth (PEG)

For valuing profitable companies with growth potential
OGN is good value based... subscribe to Premium to read more.
PEG Value Valuation

OGN's financial health

Profit margin

Revenue
$1.5B
Net Income
$227.0M
Profit Margin
14.8%
OGN's Earnings (EBIT) of $1.45B... subscribe to Premium to read more.
Interest Coverage Financials
OGN's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$10.4B
Liabilities
$11.5B
Debt to equity
-10.79
OGN's short-term assets ($3.59B) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
OGN's long-term liabilities ($9.18B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
OGN's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
OGN's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
$317.0M
Investing
-$213.0M
Financing
-$77.0M
OGN's operating cash flow ($638.00M)... subscribe to Premium to read more.
Debt Coverage Financials

OGN vs General Drug Manufacturer Stocks

TickerMarket Cap1d %P/EP/B
OGN$7.57B-2.14%7.48x-7.10x
GRFS$6.67B+0.83%31.91x1.11x
TSVT$535.76M+1.00%N/A1.66x
HZNP$24.86B-0.10%43.70x4.94x
BIIB$40.84B-1.35%14.41x3.20x

Organon & Co Stock FAQ

What is Organon & Co's quote symbol?

NYSE: OGN) Organon & Co trades on the NYSE under the ticker symbol OGN. Organon & Co stock quotes can also be displayed as NYSE: OGN.

If you're new to stock investing, here's how to buy Organon & Co stock.

What is the 52 week high and low for Organon & Co (NYSE: OGN)?

(NYSE: OGN) Organon & Co's 52-week high was $39.48, and its 52-week low was $22.88. It is currently -24.61% from its 52-week high and 30.07% from its 52-week low.

How much is Organon & Co stock worth today?

(NYSE: OGN) Organon & Co currently has 254,364,409 outstanding shares. With Organon & Co stock trading at $29.76 per share, the total value of Organon & Co stock (market capitalization) is $7.57B.

Organon & Co stock was originally listed at a price of $33.25 in May 14, 2021. If you had invested in Organon & Co stock at $33.25, your return over the last 1 years would have been -10.5%, for an annualized return of -10.5% (not including any dividends or dividend reinvestments).

How much is Organon & Co's stock price per share?

(NYSE: OGN) Organon & Co stock price per share is $29.76 today (as of Feb 3, 2023).

What is Organon & Co's Market Cap?

(NYSE: OGN) Organon & Co's market cap is $7.57B, as of Feb 5, 2023.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Organon & Co's market cap is calculated by multiplying OGN's current stock price of $29.76 by OGN's total outstanding shares of 254,364,409.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.